Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Biomatrix files 510K submission for sinus surgery adhesion prevention device

Dec. 23, 1999

Novartis discloses several new compounds for proliferative, inflammatory conditions

Dec. 22, 1999

Soltec enters strategic alliance with Mipharm

Dec. 22, 1999

Anti-CD11a enters phase III for psoriasis

Dec. 21, 1999

Cellegy to conduct second phase III trial with Anogesic

Dec. 17, 1999

Pfizer investigates antipruritic activity of 4-phenylpiperidines

Dec. 16, 1999

Antiproliferative agents derived from vegetable oil in development at PharmaScience

Dec. 13, 1999

Dusa receives first approval of Levulan PDT for treatment of actinic keratoses

Dec. 10, 1999

Biogen reports phase II data for antipsoriatic agent and advances product to phase III

Dec. 8, 1999

Phase I/II results support the efficacy of ABX-IL-8 in psoriasis

Dec. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...